MGMT and glioblastoma: In one study [69], DCE and DTI metrics were extracted from a VOI of the enhancing tumor, and Ktrans exhibited significantly higher values in MGMT-methylated GBM (sensitivity/specificity/AUC 0.56/0.85/0.76), whereas other aMRI metrics and cMRI features did not differ between groups.